Tykerb

In the US, Tykerb (lapatinib systemic) is a member of the following drug classes: EGFR inhibitors, HER2 inhibitors and is used to treat Breast Cancer and Breast Cancer - Metastatic.

US matches:

• Tykerb

Ingredient matches for Tykerb

Lapatinib

Lapatinib ditosylate (a derivative of Lapatinib) is reported as an ingredient of Tykerb in the following countries:

• Australia


• Indonesia


• Japan


• New Zealand


• Oman


• United States

International Drug Name Search